January 19, 2026
The U.S. digital health market size is forecast to increase from USD 98.69 billion in 2026 to USD 266.5 billio...
Read MoreNovember 13, 2025
The hospital services market is predicted to grow from USD 13.19 trillion in 2026 to USD 28.99 trillion by 203...
Read MoreNovember 01, 2025
The osteoarthritis therapeutics market size is expected to see growth from USD 11.92 billion in 2026 to USD 24...
Read MoreMarch 04, 2026
The simulators market size is forecast to increase from USD 14.71 billion in 2026 to USD 27.59 billion by 2035...
Read MoreNovember 01, 2025
Based on market forecasts, the global advanced liver cancer market, projected at USD 2.65 billion in 2024, is expected to reach USD 8.2 billion by 2034, growing at a CAGR of 11.94% over the forecast period. Emergence of diverse severe liver issues and rising demand for advanced therapies are encouraging the global market expansion. The highl...
November 01, 2025
Based on market forecasts, the pleural biopsy sector will expand from USD 329.03 million in 2024 to USD 594.6 million by 2034, experiencing a CAGR of 6.14%. The pleural biopsy market is expanding due to rising demand for pleural diagnostics as well as increasing use of video-assisted thoracoscopic surgery. North America led the market due to the ...
November 01, 2025
The tumor fluid biopsy market is growing because this technique has drastically transformed the sector of clinical oncology, offering ease in tumor sampling, continuous monitoring by repeated sampling, inventing targeted therapeutic regimens, and screening for therapeutic resistance. North America is dominated due to advanced healthcare infrastru...
November 01, 2025
Research studies indicate that the in vivo CAR-T platform market is experiencing significant growth, driven by the rising demand for CAR-T cell therapies and ongoing technological advancements. North America leads the global market, supported by a strong presence of key industry players and a well-established research infrastructure....
November 01, 2025
According to market projections, the liquid biopsy tube sector is expected to grow from USD 1.34 billion in 2024 to USD 5.32 billion by 2034, reflecting a CAGR of 14.85%. These specialized tubes offer a revolutionary alternative to traditional biopsy methods by improving patient comfort and enabling real-time disease monitoring....
November 01, 2025
Market insights predict the global liquid biopsy IVD industry will increase from USD 2.21 billion in 2024 to USD 8.72 billion by 2034, achieving a CAGR of 14.79%. The liquid biopsy IBD market is growing due to the rising cases of cancer. North America is leading the market due to the focus on early diagnosis to prevent healthcare complications an...
November 01, 2025
According to market projections, the global immune repertoire sequencing market, valued at USD 337.43 million in 2024, is anticipated to reach USD 842.44 million by 2034, growing at a CAGR of 9.64% over the next decade. The increasing demand for a variety of therapies and the expansion of R&D are fueling the global market. North America led t...
November 01, 2025
Projections indicate that, the global hematologic malignancies treatment market increased from USD 67.32 billion in 2024 to USD 139.13 billion by 2034, experiencing a CAGR of 7.61% over the next 10 years.The global rise in the elderly population, who are more prone to blood cancers, is fueling the growth of the market. ...
November 01, 2025
According to market projections, the global high content screening market, valued at USD 1.52 billion in 2024, is anticipated to reach USD 3.12 billion by 2034, growing at a CAGR of 7.54% over the next decade.The growing new drug discovery research and the burgeoning molecular biology sector drive the market. The presence of key players and favor...
November 01, 2025
Market insights predict the global cell and gene therapy clinical trials industry will increase from USD 10.8 billion in 2024 to USD 45.31 billion by 2034, achieving a CAGR of 15.43%. Advancements in technologies such as gene editing, CAR-T therapy, and CRISPR-Cas9 have enabled the healthcare sector to address and fulfill the unmet medical needs ...
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
sales@towardshealthcare.com